Knockdown of PD-L1 in mouse renal cell carcinoma inhibits tumor growth and improve the anti-tumor effect of Sunitinib

被引：0
|
作者：
Hara, T. [1 ]
Miyake, H. [2 ]
Fujisawa, M. [1 ]
机构：
[1] Kobe Univ, Kobe, Hyogo, Japan
[2] Hamamatsu Univ, Hamamatsu, Shizuoka, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
438
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [41] Energy status dictates PD-L1 protein abundance and anti-tumor to enable blockade
    Dai, Xiaoming
    Bu, Xia
    Gao, Yan
    Guo, Jianping
    Hu, Jia
    Jiang, Cong
    Zhang, Zhao
    Xu, Kexin
    Duan, Jinzhi
    He, Shaohui
    Zhang, Jinfang
    Wan, Lixin
    Liu, Tianjie
    Zhou, Xiaobo
    Hung, Mien-Chie
    Freeman, Gordon J.
    Wei, Wenyi
    MOLECULAR CELL, 2021, 81 (11) : 2317 - +
  • [42] A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity
    Luan, Yan
    Chai, Dafei
    Peng, Jianjian
    Ma, Shuli
    Wang, Min
    Ma, Hui
    Li, Xiang
    Fu, Shilong
    Pan, Xiaolong
    Wang, Xiaoxiao
    Qin, Songbing
    Xu, Ting
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 31 : 248 - 256
  • [43] BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
    Zhu, Hengrui
    Bengsch, Fee
    Svoronos, Nikolaos
    Rutkowski, Melanie R.
    Bitler, Benjamin G.
    Allegrezza, Michael J.
    Yokoyama, Yuhki
    Kossenkov, Andrew V.
    Bradner, James E.
    Conejo-Garcia, Jose R.
    Zhang, Rugang
    CELL REPORTS, 2016, 16 (11): : 2829 - 2837
  • [44] A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
    Cui, Xiaopei
    Jia, Huifeng
    Xin, Hong
    Zhang, Lei
    Chen, Shi
    Xia, Simin
    Li, Xue
    Xu, Wei
    Chen, Xiaofang
    Feng, Yujie
    Wei, Xiaoyue
    Yu, Haijia
    Wang, Yanting
    Zhan, Yifan
    Zhu, Xiangyang
    Zhang, Xuemei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] Targeting Glutamine Metabolism and PD-L1: A Novel Anti-tumor Pas de Deux
    Matias, Maria I.
    Dardalhon, Valerie
    Taylor, Naomi
    MOLECULAR CELL, 2020, 80 (04) : 555 - 557
  • [46] MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity
    Xiong, Wei
    Deng, Huanghao
    Huang, Changkun
    Zen, Chong
    Jian, Chengzhu
    Ye, Kun
    Zhong, Zhaohui
    Zhao, Xiaokun
    Zhu, Liang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (02): : 454 - 463
  • [47] Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade
    Jiang, Yuying
    Yang, Yongbing
    Hu, Yingchao
    Yang, Rui
    Huang, Jiajia
    Liu, Yi
    Wu, Yuqing
    Li, Sheng
    Ma, Chunmei
    Humphries, Fiachra
    Wang, Bingwei
    Wang, Xi
    Hu, Zhibin
    Yang, Shuo
    CELL REPORTS, 2022, 41 (04):
  • [48] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
    Li, Jinghan
    Shi, Daiwang
    Li, Siyi
    Shi, Xiang
    Liu, Yu
    Zhang, Yi
    Wang, Gebang
    Zhang, Chenlei
    Xia, Tian
    Piao, Hai-long
    Liu, Hong-Xu
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [49] PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma
    Mitteldorf, Christina
    Berisha, Arbeneshe
    Tronnier, Michael
    Pfaltz, Monique C.
    Kempf, Werner
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (09) : 740 - 746
  • [50] Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression
    Tsimafeyeu, Ilya
    MEDICAL SCIENCES, 2024, 12 (03)
12345